206 related articles for article (PubMed ID: 33582846)
21. Cancer cell line microarray as a novel screening method for identification of radioresistance biomarkers in head and neck squamous cell carcinoma.
Routila J; Suvila K; Grénman R; Leivo I; Westermarck J; Ventelä S
BMC Cancer; 2021 Jul; 21(1):868. PubMed ID: 34320941
[TBL] [Abstract][Full Text] [Related]
22. A Novel Ferroptosis-Related Gene Signature to Predict Prognosis in Patients with Head and Neck Squamous Cell Carcinoma.
Xu L; Li YY; Zhang YC; Wu YX; Guo DD; Long D; Liu ZH
Dis Markers; 2021; 2021():5759927. PubMed ID: 34853622
[TBL] [Abstract][Full Text] [Related]
23. The prognostic value of Tiam1 protein expression in head and neck squamous cell carcinoma: a retrospective study.
Yang H; Cai YC; Cao Y; Song M; An X; Xia Y; Wei J; Jiang WQ; Shi YX
Chin J Cancer; 2015 Sep; 34(12):614-21. PubMed ID: 26369827
[TBL] [Abstract][Full Text] [Related]
24. Biomarker signatures for primary radiochemotherapy of locally advanced HNSCC - Hypothesis generation on a multicentre cohort of the DKTK-ROG.
Löck S; Linge A; Lohaus F; Ebert N; Gudziol V; Nowak A; Tinhofer I; Kalinauskaite G; Guberina M; Stuschke M; Balermpas P; von der Grün J; Grosu AL; Debus J; Ganswindt U; Belka C; Peeken JC; Combs SE; De-Colle C; Zips D; Baretton GB; Krause M; Baumann M;
Radiother Oncol; 2022 Apr; 169():8-14. PubMed ID: 35182686
[TBL] [Abstract][Full Text] [Related]
25. Identification of an autophagy-related prognostic signature in head and neck squamous cell carcinoma.
Jiang Y; Li Y; Ge H; Wu Y; Zhang Y; Guo S; Zhang P; Cheng J; Wang Y
J Oral Pathol Med; 2021 Nov; 50(10):1040-1049. PubMed ID: 34358365
[TBL] [Abstract][Full Text] [Related]
26. Expression level of PD-L1 is involved in ALDH1A1-mediated poor prognosis in patients with head and neck squamous cell carcinoma.
Zhou AL; Wang X; Yu W; Yang L; Wei F; Sun Q; Wang Y; Kou F; Dong R; Ren X; Zhang X
Pathol Res Pract; 2020 Sep; 216(9):153093. PubMed ID: 32825960
[TBL] [Abstract][Full Text] [Related]
27. MRI-based radiomic signature as predictive marker for patients with head and neck squamous cell carcinoma.
Yuan Y; Ren J; Shi Y; Tao X
Eur J Radiol; 2019 Aug; 117():193-198. PubMed ID: 31307647
[TBL] [Abstract][Full Text] [Related]
28. An Australian retrospective study to evaluate the prognostic role of p53 and eIF4E cancer markers in patients with head and neck squamous cell carcinoma (HNSCC): study protocol.
Singh J; Jayaraj R; Baxi S; Mileva M; Curtin J; Thomas M
Asian Pac J Cancer Prev; 2013; 14(8):4717-21. PubMed ID: 24083732
[TBL] [Abstract][Full Text] [Related]
29. Immune gene expression in head and neck squamous cell carcinoma patients.
Lecerf C; Kamal M; Vacher S; Chemlali W; Schnitzler A; Morel C; Dubot C; Jeannot E; Meseure D; Klijanienko J; Mariani O; Borcoman E; Calugaru V; Badois N; Chilles A; Lesnik M; Krhili S; Choussy O; Hoffmann C; Piaggio E; Bieche I; Le Tourneau C
Eur J Cancer; 2019 Nov; 121():210-223. PubMed ID: 31593831
[TBL] [Abstract][Full Text] [Related]
30. Prognostic Correlation of an Autophagy-Related Gene Signature in Patients with Head and Neck Squamous Cell Carcinoma.
Yang C; Mei H; Peng L; Jiang F; Xie B; Li J
Comput Math Methods Med; 2020; 2020():7397132. PubMed ID: 33456497
[TBL] [Abstract][Full Text] [Related]
31. FGFR1 Is a Potential Prognostic Biomarker and Therapeutic Target in Head and Neck Squamous Cell Carcinoma.
Koole K; Brunen D; van Kempen PM; Noorlag R; de Bree R; Lieftink C; van Es RJ; Bernards R; Willems SM
Clin Cancer Res; 2016 Aug; 22(15):3884-93. PubMed ID: 26936917
[TBL] [Abstract][Full Text] [Related]
32. Role of cancer stem cell markers ALDH1, BCL11B, BMI-1, and CD44 in the prognosis of advanced HNSCC.
Jakob M; Sharaf K; Schirmer M; Leu M; Küffer S; Bertlich M; Ihler F; Haubner F; Canis M; Kitz J
Strahlenther Onkol; 2021 Mar; 197(3):231-245. PubMed ID: 32588101
[TBL] [Abstract][Full Text] [Related]
33. Squamous cell carcinoma antigen as a prognostic marker and its correlation with clinicopathological features in head and neck squamous cell carcinoma: Systematic review and meta-analysis.
Travassos DC; Fernandes D; Massucato EMS; Navarro CM; Bufalino A
J Oral Pathol Med; 2018 Jan; 47(1):3-10. PubMed ID: 28600896
[TBL] [Abstract][Full Text] [Related]
34. HOTTIP Functions as a Key Candidate Biomarker in Head and Neck Squamous Cell Carcinoma by Integrated Bioinformatic Analysis.
Yin X; Yang W; Xie J; Wei Z; Tang C; Song C; Wang Y; Cai Y; Xu W; Han W
Biomed Res Int; 2019; 2019():5450617. PubMed ID: 31032351
[TBL] [Abstract][Full Text] [Related]
35. Serum prognostic biomarkers in head and neck cancer patients.
Lin HS; Siddiq F; Talwar HS; Chen W; Voichita C; Draghici S; Jeyapalan G; Chatterjee M; Fribley A; Yoo GH; Sethi S; Kim H; Sukari A; Folbe AJ; Tainsky MA
Laryngoscope; 2014 Aug; 124(8):1819-26. PubMed ID: 24347532
[TBL] [Abstract][Full Text] [Related]
36. Identification of Novel Prognostic Biomarkers in Head and Neck Squamous Cell Carcinoma using Bioinformatics Analysis.
Ding Y; Li M; Tayier T; Chen L; Feng S
Comb Chem High Throughput Screen; 2021; 24(9):1351-1363. PubMed ID: 33109035
[TBL] [Abstract][Full Text] [Related]
37. c-Met expression is a marker of poor prognosis in patients with locally advanced head and neck squamous cell carcinoma treated with chemoradiation.
Baschnagel AM; Williams L; Hanna A; Chen PY; Krauss DJ; Pruetz BL; Akervall J; Wilson GD
Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):701-7. PubMed ID: 24521684
[TBL] [Abstract][Full Text] [Related]
38. Prognostic implication of proteomic profiles in head and neck squamous cell carcinoma.
Wu D; Gong P; Zeng Q; Zhang W; Xie F; Zhou X
Clin Chim Acta; 2020 Oct; 509():304-309. PubMed ID: 32569632
[TBL] [Abstract][Full Text] [Related]
39. Fibroblast Growth Factor Receptor Family Members as Prognostic Biomarkers in Head and Neck Squamous Cell Carcinoma: A Systematic Review.
Ipenburg NA; Koole K; Liem KS; van Kempen PM; Koole R; van Diest PJ; van Es RJ; Willems SM
Target Oncol; 2016 Feb; 11(1):17-27. PubMed ID: 26115874
[TBL] [Abstract][Full Text] [Related]
40. Identification of Immune-Related Prognostic Biomarkers Associated with HPV-Positive Head and Neck Squamous Cell Carcinoma.
Chen Y; Nie J; Li X; Fan T; Deng X; Liang D; Song G
J Immunol Res; 2021; 2021():6661625. PubMed ID: 33506058
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]